ATE271042T1 - Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren - Google Patents

Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren

Info

Publication number: ATE271042T1
Authority: AT; Austria
Prior art keywords: pets; pyrimidine; farm animals; endothelin antagonists; endothelin
Prior art date: 2000-02-11

Application number

AT01902578T

Other languages

English (en)

Inventor

Bernard J Banks

Adrian P Foster

Stephen P Gibson

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-11

Filing date

2001-02-06

Publication date

2004-07-15

2001-02-06 Application filed by Pfizer filed Critical Pfizer

2004-07-15 Application granted granted Critical

2004-07-15 Publication of ATE271042T1 publication Critical patent/ATE271042T1/de

Links

102000002045 Endothelin Human genes 0.000 title abstract 2
108050009340 Endothelin Proteins 0.000 title abstract 2
241001465754 Metazoa Species 0.000 title abstract 2
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title abstract 2
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
241000282472 Canis lupus familiaris Species 0.000 abstract 1
241000283086 Equidae Species 0.000 abstract 1
241000282326 Felis catus Species 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Chemical Treatment Of Metals (AREA)

AT01902578T 2000-02-11 2001-02-06 Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren ATE271042T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0003234.2A GB0003234D0 (en)	2000-02-11	2000-02-11	Method of treatment
PCT/IB2001/000142 WO2001058882A1 (en)	2000-02-11	2001-02-06	Use of pyrimidine endothelin antagonists in companion animals

Publications (1)

Publication Number	Publication Date
ATE271042T1 true ATE271042T1 (de)	2004-07-15

Family

ID=9885465

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01902578T ATE271042T1 (de)	2000-02-11	2001-02-06	Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren

Country Status (17)

Country	Link
EP (1)	EP1254120B1 (de)
JP (1)	JP2003528050A (de)
KR (1)	KR20020075791A (de)
AT (1)	ATE271042T1 (de)
AU (1)	AU3043601A (de)
CA (1)	CA2398007A1 (de)
DE (1)	DE60104283T2 (de)
DK (1)	DK1254120T3 (de)
ES (1)	ES2222975T3 (de)
GB (1)	GB0003234D0 (de)
HU (1)	HUP0204370A3 (de)
IL (1)	IL150488A0 (de)
NZ (1)	NZ519002A (de)
PT (1)	PT1254120E (de)
TR (1)	TR200401815T4 (de)
WO (1)	WO2001058882A1 (de)
ZA (1)	ZA200206343B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8647660B2 (en)	2004-12-29	2014-02-11	Hill's Pet Nutrition, Inc.	Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
AU2006236345B2 (en) *	2005-04-19	2011-03-31	Hill's Pet Nutrition, Inc.	Methods and compositions for the prevention and treatment of kidney disease
US8778617B2 (en) *	2010-02-25	2014-07-15	Hoffmann-La Roche Inc.	Method for determining the binding constant of high affinity compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3087968B2 (ja) *	1995-12-20	2000-09-18	山之内製薬株式会社	アリールエテンスルホンアミド誘導体及びその医薬組成物
WO1998057938A1 (en) *	1997-06-19	1998-12-23	Yamanouchi Pharmaceutical Co., Ltd.	Substituted lower alkanesulfonamide derivatives and pharmaceutical composition containing the same

2000
- 2000-02-11 GB GBGB0003234.2A patent/GB0003234D0/en not_active Ceased
2001
- 2001-02-06 WO PCT/IB2001/000142 patent/WO2001058882A1/en not_active Ceased
- 2001-02-06 AU AU30436/01A patent/AU3043601A/en not_active Abandoned
- 2001-02-06 HU HU0204370A patent/HUP0204370A3/hu unknown
- 2001-02-06 DE DE2001604283 patent/DE60104283T2/de not_active Expired - Fee Related
- 2001-02-06 PT PT01902578T patent/PT1254120E/pt unknown
- 2001-02-06 CA CA002398007A patent/CA2398007A1/en not_active Abandoned
- 2001-02-06 JP JP2001558433A patent/JP2003528050A/ja not_active Withdrawn
- 2001-02-06 KR KR1020027010354A patent/KR20020075791A/ko not_active Ceased
- 2001-02-06 NZ NZ519002A patent/NZ519002A/en unknown
- 2001-02-06 DK DK01902578T patent/DK1254120T3/da active
- 2001-02-06 AT AT01902578T patent/ATE271042T1/de not_active IP Right Cessation
- 2001-02-06 IL IL15048801A patent/IL150488A0/xx unknown
- 2001-02-06 TR TR2004/01815T patent/TR200401815T4/xx unknown
- 2001-02-06 ES ES01902578T patent/ES2222975T3/es not_active Expired - Lifetime
- 2001-02-06 EP EP01902578A patent/EP1254120B1/de not_active Expired - Lifetime
2002
- 2002-08-08 ZA ZA200206343A patent/ZA200206343B/xx unknown

Also Published As

Publication number	Publication date
EP1254120B1 (de)	2004-07-14
HUP0204370A2 (en)	2003-05-28
GB0003234D0 (en)	2000-04-05
DE60104283T2 (de)	2004-11-18
AU3043601A (en)	2001-08-20
KR20020075791A (ko)	2002-10-05
ZA200206343B (en)	2003-08-08
IL150488A0 (en)	2002-12-01
HUP0204370A3 (en)	2003-07-28
ES2222975T3 (es)	2005-02-16
CA2398007A1 (en)	2001-08-16
TR200401815T4 (tr)	2004-08-23
JP2003528050A (ja)	2003-09-24
EP1254120A1 (de)	2002-11-06
DK1254120T3 (da)	2004-10-04
DE60104283D1 (de)	2004-08-19
WO2001058882A1 (en)	2001-08-16
PT1254120E (pt)	2004-10-29
NZ519002A (en)	2004-06-25

Legal Events

Date

Code

Title

Description

2005-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1254120

Country of ref document: EP

2006-11-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE287217T1 (de)	2005-02-15	Verwendung von kreatin als futterzusatz
EP1573314A4 (de)	2006-07-26	Menschliches cd20 exprimierendetransgene mäuse
ATE439762T1 (de)	2009-09-15	Verwaltungssystem von lebendem inventar und verfahren zur trenngewichtfütterung
ITMO910147A1 (it)	1993-04-03	Tavolo per asciugatura e toellettatura cani, gatti e altri animali domestici.
CH692893A8 (fr)	2003-02-14	Composition insecticide contre les puces des mammifères, notamment des chiens et chats.
TR200401584T4 (tr)	2004-09-21	Bir kontrollü salımlı matris içeren, hayvan besininde kullanım için bileşim, bu bileşimin hazırlanması için işlem ve bu bileşimin kullanımı
HN2004000023A (es)	2007-11-23	Mascadura para animales
NO964912D0 (no)	1996-11-19	Tyggbare flubendazoltabletter for selskapsdyr
ATE336177T1 (de)	2006-09-15	Hypoallergene diätetische zusammensetzung für haustiere.
UA87297C2 (ru)	2009-07-10	Противопаразитарный кормовой премикс для животных и способ его получения
AR019065A1 (es)	2001-12-26	Uso de compuesto de 1,2-dihidroquinolina sustituida
DE50000911D1 (de)	2003-01-23	Hufeisenartiger, plattenförmiger Hufbeschlag aus Kunststoff
ATE271042T1 (de)	2004-07-15	Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren
BRPI0413025A8 (pt)	2018-03-13	compostos orgânicos
BRPI0401575A (pt)	2005-02-09	Cerca móvel controlável para gado
ES1051709Y (es)	2003-05-01	Fosa para la descomposicion de cadaveres animales.
ATE245604T1 (de)	2003-08-15	Verwendung von porphyrinderivaten in aquarien
ATE31306T1 (de)	1987-12-15	Chinazolinon-derivate wirksam gegen coccidiosis.
IT1307023B1 (it)	2001-10-23	Articoli per la masticazione di animali.
ATE120334T1 (de)	1995-04-15	Streu für die tierhaltung.
Pain	2000	My pet possum
ATE332647T1 (de)	2006-08-15	Verwendung von quillaja-pulver
KR20200008202A (ko)	2020-01-28	반려견 교배 어플
IT1318718B1 (it)	2003-09-10	Batteria per l'allevamento di avicoli o di altri animali daallevamento
JP1749759S (ja)	2023-07-31	グルーミングテーブル用クランプ